Loading…
Based on limited metadata, the FDA issued a warning letter to Hi Tech Pharmaceuticals on April 10, 2019, regarding dietary supplement products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA dietary supplement regulatory oversight, though the specific issuing office and exact violation count are not documented in this metadata. A complete review of the full warning letter would be necessary to identify the particular compliance issues cited.